Kendle International Inc. (KNDL) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Kendle International Inc. (KNDL)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: D. K. G. who wrote (4)	1/26/1998 4:13:00 PM
From: Alan M. Solinger	Read Replies (2) of 53

In general...... CRO's by definition have no real buy-in to the projects or the background knowledge for full understanding of the process/product being evaluated. This leads to inefficiency and, therefore, higher costs and longer timelines. In principal, the CRO concept is a good one. In particular, they are good for the small/start-up company that does not have the infastructure to run their own trials/protocols. They are also good for the mega-trials run by the large companies who need supplementation of their own staffs. Overall, they are expensive, inefficient, cumbersome, duplicative -- but, needed. Hope this helps.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next